July 7, 2020

The Niche

Knoepfler lab stem cell blog

CRISPR meeting

3 min read

Here is another of my blog posts from yesterday’s CRISPR ethics, science, and policy symposium held here at UC Davis. You can read the others here, here, and here. Note as with the other posts, since I was taking notes as listening and on the fly, this post is a stream of consciousness on what the speakers said so it is rough and there are some fragments. The next panel at the UC Davis CRISPR meeting included these speakers: Michael J. Zerbe, PhD, York College …Read More

3 min read

The second session at our CRISPR meeting was really powerful. As with other posts from the UC Davis CRISPR meeting, since I was taking notes on the fly during this session, this post is a stream of bits from the different talks, often trying to capture the essence of key questions or ideas as the speakers talked so forgive the format. Overall from this session, the potential future somatic-gene therapy kind of use of CRISPR for catastrophic, fatal diseases such as Huntington’s Disease is something …Read More

1 min read

There’s a great meeting going on today here at UC Davis starting soon on CRISPR, focused on the intersection of the science with bioethical and legal issues. I’ve been helping to organize this meeting, but kudos and thanks go to my colleague Mark Yarborough who took the lead in organizing the meeting and did most of the work. I’m hoping as time permits to do a few semi-live blog posts on the meeting as it goes along. If things are too busy, I will …Read More

1 min read

Several of us here at UC Davis and other Northern California institutions have worked together to organize a unique symposium on CRISPR and genetic modification. You are invited to attend the free meeting, which will take place on May 26th. You can register here. We will cover CRISPR ethics, policy, and law as they relate both to modification of humans and other organisms. We have a wonderful lineup of speakers that include a diverse panel of scientists, policy makers, and at least one patient. You …Read More